Sirio Pharma Co., Ltd. (SHE:300791)
China
· Delayed Price · Currency is CNY 25.17
-0.04 (-0.16%)
Apr 29, 2025, 3:04 PM CST
Sirio Pharma Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 28, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Market Capitalization | 5,930 | 6,167 | 6,293 | 6,637 | 7,513 | 11,035 | Upgrade
|
| Market Cap Growth | -6.24% | -2.01% | -5.18% | -11.66% | -31.92% | 123.46% | Upgrade
|
| Enterprise Value | 6,980 | 7,186 | 7,062 | 6,079 | 7,014 | 10,638 | Upgrade
|
| Last Close Price | 25.17 | 26.33 | 25.83 | 27.10 | 30.23 | 44.11 | Upgrade
|
| PE Ratio | 17.75 | 18.97 | 22.39 | 31.26 | 32.41 | 42.88 | Upgrade
|
| Forward PE | 15.12 | 15.13 | 19.62 | 25.54 | - | - | Upgrade
|
| PS Ratio | 1.41 | 1.46 | 1.76 | 2.65 | 3.17 | 5.34 | Upgrade
|
| PB Ratio | 2.18 | 2.34 | 2.45 | 2.46 | 2.95 | 5.06 | Upgrade
|
| P/TBV Ratio | 3.59 | 3.95 | 4.42 | 2.81 | 3.38 | 5.88 | Upgrade
|
| P/FCF Ratio | 19.19 | 39.83 | - | 43.90 | - | 114.44 | Upgrade
|
| P/OCF Ratio | 8.44 | 10.88 | 16.30 | 14.92 | 22.01 | 34.53 | Upgrade
|
| EV/Sales Ratio | 1.66 | 1.71 | 1.97 | 2.42 | 2.96 | 5.15 | Upgrade
|
| EV/EBITDA Ratio | 10.45 | 11.19 | 12.22 | 16.57 | 18.49 | 30.09 | Upgrade
|
| EV/EBIT Ratio | 16.30 | 16.40 | 18.77 | 25.06 | 24.95 | 38.85 | Upgrade
|
| EV/FCF Ratio | 22.58 | 46.41 | - | 40.21 | - | 110.32 | Upgrade
|
| Debt / Equity Ratio | 0.60 | 0.61 | 0.53 | 0.35 | 0.34 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 2.42 | 2.37 | 2.23 | 2.50 | 2.27 | 0.10 | Upgrade
|
| Debt / FCF Ratio | 5.24 | 10.38 | - | 6.20 | - | 0.36 | Upgrade
|
| Asset Turnover | 0.79 | 0.79 | 0.76 | 0.63 | 0.73 | 0.83 | Upgrade
|
| Inventory Turnover | 5.52 | 6.00 | 7.02 | 7.36 | 6.34 | 5.97 | Upgrade
|
| Quick Ratio | 1.59 | 1.79 | 1.88 | 4.62 | 4.88 | 2.59 | Upgrade
|
| Current Ratio | 2.26 | 2.45 | 2.57 | 5.18 | 5.76 | 3.42 | Upgrade
|
| Return on Equity (ROE) | 9.87% | 10.83% | 9.12% | 8.09% | 9.81% | 12.47% | Upgrade
|
| Return on Assets (ROA) | 4.98% | 5.13% | 5.01% | 3.79% | 5.43% | 6.83% | Upgrade
|
| Return on Capital (ROIC) | 6.05% | 6.69% | 6.21% | 4.30% | 6.23% | 8.03% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.00% | 9.40% | 8.50% | 6.50% | 8.10% | 12.10% | Upgrade
|
| Earnings Yield | 5.58% | 5.27% | 4.47% | 3.20% | 3.09% | 2.33% | Upgrade
|
| FCF Yield | 5.21% | 2.51% | -1.04% | 2.28% | -2.44% | 0.87% | Upgrade
|
| Dividend Yield | 3.36% | - | 3.28% | 0.99% | 1.02% | 0.70% | Upgrade
|
| Payout Ratio | 66.72% | 67.56% | 29.83% | 35.84% | 31.29% | 10.05% | Upgrade
|
| Buyback Yield / Dilution | 0.65% | 0.36% | 0.81% | 4.47% | -5.00% | -23.77% | Upgrade
|
| Total Shareholder Return | 4.01% | 0.36% | 4.08% | 5.46% | -3.98% | -23.08% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.